Princess Margaret Cancer Centre/University Health Network
Princess Margaret Cancer Centre/University Health Network
Toronto, Ontario, Canada1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase II Study of CAmizestrant in Resectable Endometrial Adenocarcinoma | Early Stage Endometrial Cancer; Estrogen Receptor-positive | Not yet recruiting | Phase 2 | 2026-09-25 | NCT07840443 |